about
Muscular effects of statins in the elderly female: a reviewHIV Infection in the Elderly: Arising ChallengesNeuromuscular blockade in the elderly patientExtrinsic risk factors for pressure ulcers early in the hospital stay: a nested case-control study.Community-acquired pneumonia in elderly patients.A population-based study on the association between acute renal failure (ARF) and the duration of polypharmacy.Innovative collaborative practice to optimize pharmacotherapy for frail older patients.The relationship of psychological reactance, health locus of control and sense of self-efficacy with adherence to treatment in psychiatric outpatients with depression.Pain management in the elderly population: a review.Pharmacy practice, research, education, and advocacy for older adults.Drug-Drug Interaction Potentials of Tyrosine Kinase Inhibitors via Inhibition of UDP-Glucuronosyltransferases.Assessment of medication-related problems in geriatric patients of a rural tertiary care hospital.Drug-induced falls in older persons: is there a role for therapeutic drug monitoring?Pharmacologic management of the older woman undergoing surgeryPolypharmacy: misleading, but manageable.The grapefruit: an old wine in a new glass? Metabolic and cardiovascular perspectives.Pharmacological pain management in the elderly patient.Managing hypertension in the elderly in light of the changes during aging.Application of STOPP and START criteria: interrater reliability among pharmacists.Identification and management of in-hospital drug-induced delirium in older patients.Treatment of type 2 diabetes in the elderly.The value of drug and metabolite concentration in blood as a biomarker of psychopharmacological therapy.Pharmacotherapeutic management of metastatic, castration-resistant prostate cancer in the elderly: focus on non-chemotherapy agents.Impact of renal aging on drug therapy.A Pharmacist-Physician Intervention Model Using a Computerized Alert System to Reduce High-Risk Medication Use in Elderly Inpatients.Are elderly and women under-represented in cardiovascular clinical trials? Implication for treatment.Reduction in targeted potentially inappropriate medication use in elderly inpatients: a pragmatic randomized controlled trial.Systemic glucocorticoid use in Denmark: a population-based prevalence study.Pain severity and pharmacologic pain management among community-living older adults: the MOBILIZE Boston study.Tablet splitting of narrow therapeutic index drugs: a nationwide survey in Taiwan.Not Geropharmacotherapy 101.Characteristics of elderly patients who consider over-the-counter medications as safe.Post mortem toxicology in the elderly.Population analyses of atorvastatin clearance in patients living in the community and in nursing homes.Safety and efficacy of the oral direct renin inhibitor aliskiren in elderly patients with hypertension.Association Between Anticholinergic Drug Use and Health-Related Quality of Life in Community-Dwelling Older Adults.Relations of osteoporosis and follow-up duration to recurrent falls in older men and women.Effects of age and sex on the pharmacokinetics of LCZ696, an angiotensin receptor neprilysin inhibitor.Disparate inclusion of older adults in clinical trials: priorities and opportunities for policy and practice change.HIV infection in the elderly.
P2860
Q27023343-E1ED8C1D-9D6A-43F8-A885-7453C9981078Q28076000-8200B30C-70E0-405F-9D05-E9DAD6D53FF7Q28076494-0C2D8479-B360-4E14-ACF0-4E8A9BC513CCQ33737594-11E6ADC0-E0BB-44D7-B41F-24B0A020EAC8Q34048462-579FBABD-A160-4834-819B-54CD93507245Q34398423-7AE3EB48-7603-4918-B482-D10931D82B3BQ34427867-ADA22D9B-A065-4C9D-A9EC-86B99A94E063Q34568863-387BCD3A-DF46-4A27-94D3-99E15EAB0569Q34986245-A48D27F7-CC2C-42A7-A3FD-7EAC3A1E28BBQ36268399-9D73D560-A0C7-433A-AC3E-505C8F3473DDQ36353657-9F77D097-DE5E-41F9-AC17-169799005E13Q36612508-34EC7C94-2C8E-4017-AFA5-A9B2CB0C2D9BQ36672220-14EA63A6-FE9A-469D-A946-AE8E5FE05707Q36879058-9CED5FA6-5948-42ED-A8A1-CB2CA6012BB5Q36897474-A8525E60-5E73-43DD-B5CB-C798709F7E06Q37041734-4C3FAC6F-E920-4AD8-B042-C5C6609BFC01Q37069052-4B933D9A-6851-4B30-BF0E-70D21DBF1A94Q37229310-F0A06C0D-5F5B-4750-B1F1-52CA3CA4F931Q37543893-FF56F64E-2BBE-4FE1-A0F0-8AA0B52B8B4AQ37931232-144A105C-CA5F-48ED-818E-0035CD79E0ADQ38000974-67FC3B5C-14E2-4A9A-BEC3-33D2F2CA8514Q38154910-8D6C83A4-9B5A-4AAD-9FBD-4C78AD87CA3CQ38267175-F660225E-1211-4CFA-AF78-01077EFDBD4DQ38544072-A9741F25-84CB-4E00-91AE-69BF6C58BFE9Q38561862-510EC374-3651-4F23-A8E3-5431DAC3E621Q38961330-E50DBB92-0D14-4EAF-871A-1466F75B23CDQ40119009-565DE438-86F6-4DA5-8F24-EF8204BF2502Q40181753-A52EA145-0B23-4921-B4C5-2262E7D95570Q40324422-6E0A8A43-6A0C-44DB-8F69-037899662AF7Q40509651-03652243-5DA4-473B-B860-B7CBC820EE0AQ43122700-4983AA2D-A266-45A1-8752-72E1E85B7F23Q43748792-06A19F2C-FCF9-48B0-A286-90DED6B7194BQ44409586-60BAD1BC-7D3A-4046-B396-C0AD00009706Q45942816-3B2214A5-7F78-4A7E-9198-36ED77DFD74FQ46866932-06435522-3F22-43B5-B257-70C4B5C58DE1Q47648971-DE8FF58C-22D1-4DDF-BF0F-CA8D1C9F281AQ48411084-8A0D9D04-1272-4E85-A266-092AD174B8CDQ51016419-1B5D91B0-1909-4428-BC64-DFE5A35EAE7CQ53064501-D0DBAA34-DFDC-4BD2-8444-DED30936BEA9Q53723664-CCEE95C6-EB8C-430F-8D2B-7F55B6AD537A
P2860
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
2003年论文
@zh
2003年论文
@zh-cn
name
Principles of drug therapy for the elderly patient.
@ast
Principles of drug therapy for the elderly patient.
@en
type
label
Principles of drug therapy for the elderly patient.
@ast
Principles of drug therapy for the elderly patient.
@en
prefLabel
Principles of drug therapy for the elderly patient.
@ast
Principles of drug therapy for the elderly patient.
@en
P356
P1476
Principles of drug therapy for the elderly patient.
@en
P2093
Joseph J Bahl
Rubin Bressler
P304
P356
10.4065/78.12.1564
P407
P577
2003-12-01T00:00:00Z